Navigation Links
Interactive Teleconference on Inflammatory Bowel Disease for Patients, Caregivers, and Healthcare Professionals
Date:1/29/2008

Educational teleconference on medical therapies to feature Mayo Clinic

physician

NEW YORK, Jan. 29 /PRNewswire/ -- Crohn's disease and ulcerative colitis patients, caregivers, and healthcare professionals can now register for "Inflammatory Bowel Disease: Why Should I Take My Medications?" This free, live, interactive teleconference through the Crohn's & Colitis Foundation will take place on Thursday, March 6, from 1:00 pm to 2:15 pm EST and will address effective treatment planning for patients with Crohn's and colitis. Collectively known as inflammatory bowel disease (IBD), these painful and unpredictable digestive diseases debilitate 1.4 million Americans. The teleconference will feature Mayo Clinic College of Medicine physician, Sunanda V. Kane, MD, MSPH, Associate Professor of Medicine.

To register, call toll-free 1-877-547-5641 or visit http://www.rmei.com/ccfa. Registration is being handled by Robert Michael Educational Institute LLC.

"Patients, caregivers, and professionals will benefit from the Crohn's & Colitis Foundation's upcoming teleconference," says Kimberly Frederick, Vice President of Patient & Professional Services for the Foundation. "Dr. Kane will offer exclusive insight into IBD gained from her experience caring for patients as a board-certified physician in internal medicine-gastroenterology at the Mayo Clinic College of Medicine, and there will be added time for questions and answers from the live telephone audience."

In addition to an interactive question-and-answer session, participants will learn about various medical therapies used to treat IBD, key goals of treatment, the importance of taking medication as prescribed, and tools to help patients adhere to medical treatment plans.

Continuing education credit is being offered for nurses through the co-sponsorship of Robert Michael Educational Institute LLC and Postg
'/>"/>

SOURCE Crohn's & Colitis Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Turnaround Partners Sells Minority Ownership in Interactive Nutrition to Natural Nutrition
2. 90octane Selected as Interactive Marketing Agency for Symetix Lead Generation Program
3. DATATRAK International Launches Innovative, Interactive Educational Webcast Series
4. GetWellNetwork Introduces GetConnected2008, Healthcares First Interactive Patient Care Conference
5. Natural Nutrition Ships First InterACTIVE Nutrition Brand Products to Panama
6. Natural Nutrition Interactive Subsidiary Reports Fifteen Percent Revenue Increase in October
7. Excerpta Medica and Elsevier Interactive Solutions merge into 1 integrated provider
8. A New Interactive Consumer Experience Highlighting Successful Weight Loss Strategies is Coming to a Mall Near You
9. National Movement Disorders Interactive Experience Center Comes to Tampa Bay for First Time
10. Schwablearning.Org Launches Interactive Tool to Help Parents of Children Struggling in School
11. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)....24/PRNewswire-FirstCall/--CenteneCorporation(NYSE...edicaidhasselectedCenteneasoneoftwoCoordinatedCare...tedAccessNetwork(MississippiCAN),acoordinatedcarep...sworkingwiththeDivisiontoexecuteacontractinwhichth...,asMagnoliaHealthPlan(Magnolia). ,, BasedinJack...
(Date:11/24/2009)...ose choking hazard, are too loud, or contain dange...lthDay News) -- As the holiday shopping season beg... are still being sold in stores across the United ...ual Trouble in Toyland report, released Tuesday ... , The report focuses on toys that pose a choki...
(Date:11/24/2009)...tes didn,t differ greatly between high- and low-vo...ov. 24 (HealthDay News) -- Do hospitals that condu...best results for patients? Maybe not. , Prior r..." when it comes to artery-opening procedures, but ...ow- and high-volume hospitals performing more or l...
(Date:11/24/2009)...archers have found that hormones produced during p...he growth of breast cancer. This protein, alpha-fe...ated agent for the treatment and prevention of bre...ncer Prevention Research , a journal of the Americ... in pregnancy, such as estrogen, all induce AFP, w...
(Date:11/24/2009)...ample, study finds no added use but higher costs ,...Direct-to-consumer drug ads may contribute to high...xamined sales of the widely used antiplatelet drug...rom 1999 to 2005 for 27 state Medicaid programs fo...ogrel did not increase people,s use of the drug bu...
Breaking Medicine News(10 mins):Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Protein from pregnancy hormone may prevent breast cancer 2Health News:Advertising to Consumers May Raise Drug Prices 2
...d anti-HLA antibody assays both contribute to ...g weaned off immunosuppr...Cylex in,conjunction with the University of Pittsb... antibody assays may be independent,measures of di...
... New evidence for the first time suggests that peo...ill over time experience a progressive worsening o...w long they have the disorder, according to a new ...100 patients (50 with short-term rhinitis, and 50 ...
...ing cause of death for female survivors; cardiovas...31 (HealthDay News) -- People who survived Hodgkin...veloping and dying from another cancer or cardiova...s, according to the researchers. , "The bottom-li...
...es demonstrated potential for pazopanib as a singl...ung cancer and advanced,renal cell cancer:, -- ...ancer, 86 percent of patients who received pa...rate of 35 percent. The median duration of respons...
...medication use in young children has been linked t...ral deaths, leading the FDA to recommend against t...pite these concerns about safety and efficacy, the...( www.emnet-usa.org ) led by Katherine ODonnell, M...
...s would offer help to millions of diabetics who ar...s) -- Better screening and diagnosis for diabetes ...ans who don,t realize they have the disease, a new... Hopkins School of Medicine in Baltimore, said in ...
Other Medicine News:Health News:Cell-Mediated Immunity and Anti-HLA Antibody Tests Provide Insight to Immune Response in Renal Transplant Patients 2Health News:Cell-Mediated Immunity and Anti-HLA Antibody Tests Provide Insight to Immune Response in Renal Transplant Patients 3Health News:Hodgkin Lymphoma Kids Face Greater Risk of Future Problems 2Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 2Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 3Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 4Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 5Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 6Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 7Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 8Health News:Study examines cold medication use in young children 2Health News:Panel Calls for Better Diabetes Screening 2
(Date:11/24/2009)...swire-FirstCall/--EchoTherapeutics,Inc.(OTCBulleti...ony(TM)tCGMSystemasanon-invasive,wireless,transder...elude(TM)SkinPrepSystemfortransdermaldrugdelivery,...ChiefExecutiveOfficer,willpresentatthe13thAnnualBi...edbytheNewYorkSocietyofSecuritiesAnalysts,at2:05on...
(Date:11/24/2009)...e/--MAQUETCardiovascularLLC,aleadingproviderofcard...edaguaranteedtwo-yearcontractwithNovation,oneofthe...esolesourceproviderofsurgicaldevicesforbeatinghear...,whichrunsthroughOctober31,2012,MAQUETCardiovascul...nddisposablesuppliestothemembersofVHAInc.andUniver...
(Date:11/24/2009)...wswire-FirstCall/--IsisPharmaceuticals,Inc.(Nasdaq...ouncedthatmanagementwillpresentacompanyoverviewatP...ay,December1,2009,at10:30a.m.ETatTheNewYorkPalaceH...beavailableonthe"Investors&Media"sectionoftheC...esentationwillbeavailableontheIsisWebsitewithin48h...
Breaking Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Safe Ozone Levels May Not Be for Some 52829 1Safe Ozone Levels May Not Be for Some 52829 2Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 1Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 2Millennium Pharmaceuticals Inc Lymphoma Research Foundation funds lymphoma research 52823 1Millennium Pharmaceuticals Inc Lymphoma Research Foundation funds lymphoma research 52823 2
...DIEGO, Dec. 5 Orexigen(R) Therapeutics, Inc.,(Nas...the Company,s resources,focus its efforts on its l...ent team. , The key aspects of these changes...-of-concept Phase 2 trials for OREX-003,(zonisamid...ted weight gain),and OREX-004 (fluoxetine and nalt...
...ERDAM, December 4 Biopharmaceutical company Kiadi...completed treatment of the,last patient on its ATI...,lymphocyte cell based product, is under developme...D) and allow early immune reconstitution following...n end stage blood cancer,patients were treated wit...
Other Medicine Technology:Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team 2Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team 3Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations 2
Kerrison style punch
Aaron 2250 Electrosurgery Generator
Sabre 2400 Electrosurgery Generator, 240V, 50Hz
ExcaliburPlus PC Electrosurgery Generator, 100V, 50Hz/60Hz
Medicine Products: